The protective effects of levosimendan in post resuscitation rat cardiac function

Jian GUO,Zhengfei YANG,Qin LING,Qian YANG,Xiaoye LU,Changqing ZHU
DOI: https://doi.org/10.13201/j.issn.1009-5918.2017.12.013
2017-01-01
Abstract:Objective:To study the protective effects of levosimendan in post resuscitation rat cardiac function by establishing a rat cardiac arrest and resuscitation model with the help of echocardiography.Method:Twenty-nine healthy male SD rats were randomly divided into sham group (n=5),LEVO group (n=12) and control group (n =12).We established cardiac arrest model in control and LEVO groups.After 6 minutes untreated cardiac arrest,cardio-pulmonary resuscitation was given.We observed 6 hours.The LEVO group was treated with levosimendan during and after CPR,while the control and sham group were given equivalent volume of saline solution.The sham group was not induced into cardiac arrest,no resuscitation as well.They were used to offer baseline data for our study,together with LEVO and control group,gas analysis and echocardiography data were recorded per hour after resuscitation at 1~6 h.Result:Eleven rats were successfully resuscitated in LEVO group (91.7%),9 rats were successfully resuscitated in control group,there was no significant differences in success rate of resuscitation (P=0.590).All resuscitated rats have survived 6 hours.The cardiac function has declined dramatically in both groups,and it was getting worse with time lasts.In control group,after resuscitated 1 h,the ejection fraction has decreased from (77 ±4) % to (61± 11) %,fraction shortening has decreased from (40 ± 7) % to (26 ± 4) %,stroke volume has decreased from (0.25±0.14) ml/min to (0.17±0.05) ml/min,and cardiac output has decreased from (147± 19) ml/min to (83±25) ml/min.However,in LEVO group,the decline was not so obvious,with ejection fraction from (78±7) % to (71 ± 13) % fraction Shortening from (40± 8) % to (38 ± 7) %,Stroke volume from (0.34 ± 0.14) ml/min to (25±0.04) ml/min,and cardiac output from (146 ± 19) ml/min to (123 ± 16) ml/min,There was significant difference between two groups.The heart rate in control group after resuscitation did not change significantly compared with sham group,(P>0.05).Heart rate in LEVO appeared to be lower than control and sham groups,but no statistic difference.During observation period,cardiac function had no great change in sham group.Conclusion:We find that in our rat cardiac arrest and resuscitation model,treated with levosimendan will protect and improve the cardiac function.
What problem does this paper attempt to address?